Literature DB >> 32576444

Chr2 30297612-ALK, A Novel Intergenic Fusion With Exon18 of ALK, Responds to Crizotinib.

Xiaofeng Chen1, Guohong Zhao1, Peilin Zhong2, Min Zhang3, Rongrong Chen3, Derong Zhang4.   

Abstract

Entities:  

Keywords:  Chr2 30297612-ALK; Crizotinib; Exon 18; Intergenic fusion; Next-generation sequencing

Year:  2020        PMID： 32576444     DOI： 10.1016/j.cllc.2020.04.014

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  2 in total

1.  Characterizing kinase intergenic-breakpoint rearrangements in a large-scale lung cancer population and real-world clinical outcomes.

Authors:  Y Yao; Z Yu; Y Ma; Q Ou; X Wu; D Lu; X Li
Journal:  ESMO Open       Date:  2022-03-16

2.  Effective treatment in lung adenocarcinoma patient with brain metastases harboring novel CLHC1/RNT4 intergenic region- ALK fusion: A case report.

Authors:  Huanling Xia; Binbin Liang; Guoxiang Liu; Yingxue Qi; Ningning Luo; Mengmeng Li
Journal:  Medicine (Baltimore)       Date:  2022-04-08       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.